June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Optical coherence tomography features preceding the onset of geographic atrophy and neovascular disease
Author Affiliations & Notes
  • Giliann K Collins
    Ophthalmic Epidemiology and Genetics Service, Tufts Medical Center, Boston, Massachusetts, United States
  • Rachel E Silver
    Ophthalmic Epidemiology and Genetics Service, Tufts Medical Center, Boston, Massachusetts, United States
  • Ricardo Louzada
    New England Eye Center, Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts, United States
    Ophthalmology, Federal University of Goiás, Goiânia, Goiás, Brazil
  • Eduardo Amorim Novais
    New England Eye Center, Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts, United States
    Ophthalmology, Federal University of São Paulo (UNIFESP), São Paulo, SP, Brazil
  • Jay S Duker
    New England Eye Center, Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts, United States
  • Daniela Ferrara
    New England Eye Center, Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts, United States
  • Johanna M Seddon
    Ophthalmic Epidemiology and Genetics Service, Tufts Medical Center, Boston, Massachusetts, United States
    New England Eye Center, Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Giliann Collins, None; Rachel Silver, None; Ricardo Louzada, None; Eduardo Novais, None; Jay Duker, Alimera (C), Allergan (C), Aura Biosciences (C), Carl Zeiss Meditec (F), Carl Zeiss Meditec (C), Eleven Biotherapeutics (S), Hemera Biosciences (I), Ocudyne (C), Omeros (C), Ophthotech (I), Optovue (F), Optovue (C), pSivida Corporation (S), Santen (C), Thrombogenics (C), Topcon Medical Systems, Inc. (F), Topcon Medical Systems, Inc. (C); Daniela Ferrara, Genentech (E), Roche (I); Johanna Seddon, Apellis (C), Novartis (F)
  • Footnotes
    Support  JMS: R01-EY11309 from the National Institutes of Health; the Massachusetts Lions Eye Research Fund Inc., New Bedford, MA; International Retinal Research Foundation Inc., Birmingham, AL; and the Age-Related Macular Degeneration Research Fund, Ophthalmic Epidemiology and Genetics Service, Tufts Medical Center, Tufts University School of Medicine, Boston, MA.
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 51. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Giliann K Collins, Rachel E Silver, Ricardo Louzada, Eduardo Amorim Novais, Jay S Duker, Daniela Ferrara, Johanna M Seddon; Optical coherence tomography features preceding the onset of geographic atrophy and neovascular disease. Invest. Ophthalmol. Vis. Sci. 2017;58(8):51.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Age-related macular degeneration (AMD) is a progressive disease with multifactorial etiology. There is a need to identify robust clinical features or other biomarkers that predict advanced disease prior to irreversible visual loss. We previously assessed morphological features of the retina on spectral domain optical coherence tomography (SD-OCT) in a comparison of geographic atrophy (GA) and normal eyes (Novais EA et al. IOVS 2016;57:ARVO E-Abstract 1610). This study evaluated specific SD-OCT features to determine if they predict progression from early or intermediate disease to advanced AMD, GA, and neovascular disease (NV).

Methods : Participants were enrolled in our prospective epidemiologic studies of AMD. Those who transitioned to advanced disease were classified as progressors (n=40 eyes), and were matched on baseline AMD grade and follow up interval to participants who did not develop advanced AMD (nonprogressors; n=40 eyes). Mean follow up time was 5.4 years. Morphological SD-OCT features of the neurosensory retina, photoreceptors, and retinal pigment epithelium (RPE) were systematically evaluated by two independent graders. Logistic regression was used to evaluate the association between these SD-OCT features and progression to advanced AMD.

Results : Retinal thickness abnormalities were significantly associated with higher odds of progression to advanced AMD, GA, and NV (odds ratios [ORs]: 19.2 to 72.6; P<0.001). Disruption of the ellipsoid zone was also associated with progression to advanced AMD and NV (ORs: 17.9 and 30.6; P<0.001), with similar trends for GA. Disruption of the photoreceptor outer segments and interdigitation zone trended in the same direction for each endpoint. Drusenoid pigment epithelial detachment and RPE thickening were also associated with higher odds of progression to advanced AMD (ORs: 5.6 and 5.0; P<0.001) and NV (ORs: 17.2 and 10.8; P<0.001, P=0.003). Presence of pigmentary hyperreflective material was associated with progression to each outcome (ORs: 7.5 to 12.8; P<0.01).

Conclusions : Systematic assessment of OCT features in early or intermediate AMD showed that abnormalities at the level of photoreceptors and RPE are associated with progression to both GA and NV. These findings provide relevant insights into mechanisms of AMD progression, suggesting these two forms of advanced disease have similar etiology.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×